what is the glp 1 receptor biased agonism helpful in treatment of obesity with the GLP-1 analogues? New Insights into Beta-Cell GLP-1

Until its patents expire, other companies generally cannot market their own semaglutide medications in the US

doi: 10.1089/thy.2016.0256 265

Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss in a down market

Tumor microenvironment-responsive Fe(III)-porphyrin nanotheranostics for tumor imaging and targeted chemodynamic-photodynamic therapy

Two clinical trials were done on semaglutide and Alzheimers, and they did not show any benefits, Low Wang said

Retatrutide may be the more exciting name in todays weight-loss conversation, but tirzepatide remains the more practical option for patients who are looking for a treatment they can realistically discuss and begin now under proper medical supervision